SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+7.77%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.38B
AUM Growth
+$750M
(+28%)
Cap. Flow
+$668M
Cap. Flow
% of AUM
19.75%
Top 10 Holdings %
Top 10 Hldgs %
27.81%
Holding
544
New
135
Increased
136
Reduced
129
Closed
73
Top Buys
| 1 |
Microsoft
MSFT
|
$100M |
| 2 |
Apple
AAPL
|
$47.4M |
| 3 |
Masco
MAS
|
$45.4M |
| 4 |
McDonald's
MCD
|
$44.7M |
| 5 |
Campbell Soup
CPB
|
$37.4M |
Top Sells
| 1 |
F5
FFIV
|
$49M |
| 2 |
MSCI
MSCI
|
$30.2M |
| 3 |
Pilgrim's Pride
PPC
|
$29.4M |
| 4 |
Amdocs
DOX
|
$22.9M |
| 5 |
ANSS
Ansys
ANSS
|
$21.3M |
Sector Composition
| 1 | Consumer Discretionary | 19.08% |
| 2 | Healthcare | 18.13% |
| 3 | Technology | 17.51% |
| 4 | Industrials | 12.07% |
| 5 | Consumer Staples | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFFX
151
DELISTED
AFFYMETRIX INC
AFFX
| $1.65M | 0.05% |
163,010
-20,920
| -11% | -$211K |
|
|
DYAX
152
DELISTED
DYAX CORPORATION
DYAX
| $1.64M | 0.05% |
43,480
-6,700
| -13% | -$252K |
|
153
The Greenbrier Companies
GBX
$1.45B
| $1.63M | 0.05% |
50,027
-8,140
| -14% | -$266K |
|
154
Cytokinetics
CYTK
$5.95B
| $1.63M | 0.05% |
155,670
-21,340
| -12% | -$223K |
|
155
Qualcomm
QCOM
$172B
| $1.62M | 0.05% |
32,414
+32,369
| +71,931% | +$1.62M |
|
156
Procter & Gamble
PG
$373B
| $1.59M | 0.05% |
19,958
+19,921
| +53,841% | +$1.58M |
|
|
XCRA
157
DELISTED
Xcerra Corporation
XCRA
| $1.57M | 0.05% |
260,060
-41,220
| -14% | -$249K |
|
158
SEI Investments
SEIC
$11B
| $1.49M | 0.04% |
+28,490
| New | +$1.49M |
|
|
OUTR
159
DELISTED
OUTERWALL INC
OUTR
| $1.46M | 0.04% |
39,993
-6,350
| -14% | -$232K |
|
|
ACHN
160
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.32M | 0.04% |
122,500
-19,010
| -13% | -$205K |
|
|
SHOR
161
DELISTED
ShoreTel, Inc.
SHOR
| $1.27M | 0.04% |
+143,790
| New | +$1.27M |
|
162
United Parcel Service
UPS
$71.6B
| $1.21M | 0.04% |
+12,567
| New | +$1.21M |
|
163
New York Times
NYT
$9.64B
| $1.18M | 0.03% |
+87,860
| New | +$1.18M |
|
|
WW
164
DELISTED
WW International
WW
| $1.16M | 0.03% |
50,890
+44,020
| +641% | +$1M |
|
165
Autodesk
ADSK
$68.1B
| $1.14M | 0.03% |
+18,738
| New | +$1.14M |
|
166
Citi Trends
CTRN
$321M
| $1.14M | 0.03% |
53,480
-6,460
| -11% | -$137K |
|
167
FibroGen
FGEN
$45.7M
| $1.1M | 0.03% |
1,446
-247
| -15% | -$188K |
|
|
VAR
168
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.08M | 0.03% |
+15,194
| New | +$1.08M |
|
169
Novartis
NVS
$249B
| $1.07M | 0.03% |
+13,884
| New | +$1.07M |
|
170
Yum! Brands
YUM
$39.9B
| $1.06M | 0.03% |
+20,118
| New | +$1.06M |
|
171
Amgen
AMGN
$151B
| $1.05M | 0.03% |
6,456
+6,446
| +64,460% | +$1.05M |
|
172
Neurocrine Biosciences
NBIX
$13.9B
| $1.01M | 0.03% |
+17,870
| New | +$1.01M |
|
|
PGNX
173
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $935K | 0.03% |
152,470
-3,590
| -2% | -$22K |
|
|
NTUS
174
DELISTED
Natus Medical Inc
NTUS
| $917K | 0.03% |
19,080
-3,000
| -14% | -$144K |
|
175
Exelixis
EXEL
$10.1B
| $911K | 0.03% |
161,460
-25,410
| -14% | -$143K |
|